Resources & Expert Videos

Resources Library

Expert opinions on current DT treatments and guidelines
Get insights from two renowned experts,
Professor Bernd Kasper (Germany) and Professor Alessandro Gronchi (Italy).
ICD-10-CM codes for desmoid tumours
View ICD-10-CM diagnosis codes for desmoid tumours, that went into effect on October 1, 2023.

Patient Advocacy Groups

Sarcoma Patient Advocacy Global Network (SPAGN) is the global network of national Sarcoma Patient Advocacy Organizations. Today, more than 60 member groups from 5 continents gather under the umbrella of SPAGN, providing a common, international and influential patient voice for sarcoma patients around the globe. SPAGN is working to improve the treatment and care of sarcoma patients through information and support, and by increasing the visibility of sarcoma with policymakers and the public.1

The organisations listed are independent of SpringWorks Therapeutics, Inc. SpringWorks is providing these links to help patients find more information about desmoid tumours. Inclusion on this list does not represent an endorsement or a recommendation from SpringWorks for any group or organisation.

Helping patients replace uncertainty with understanding

Because desmoid tumours are rare,2 the diagnosis can raise more questions for patients than answers. Your patients may feel discouraged,2 like the tumour is taking over their lives.

Understanding the nature of their disease and management strategies can help reduce their confusion.

Hear from desmoid tumour experts

Start the conversation with us at these upcoming conferences

Meet us at ESMO Sarcoma and Rare Cancers Congress 2026

12-14 March 2026, Lugano, Switzerland

Join us at the conference for a conversation about desmoid tumour science and patient care. At our booth, you’ll find valuable support to elevate your clinical practice. We look forward to meeting you!

Visit us at Medical Booth #4&5 and join our scientific contributions:

Friday, 13 March, 12:45-13:45 – Hall B1, First Floor

ESMO Sarcoma and Rare Cancers Congress 2026 Industry Satellite Symposium

New Insights in the Management of Rare Tumours
Chair: Prof. Bruno Vincenzi
Agenda:

      • Prof. Bruno Vincenzi: Opening
      • Dr. Andrea Napolitano Focus on Desmoid Tumours
      • Dr. Angela HirbeDeep Dive into NF1-PN


Friday, 13 March 13, 17:35-18:15 – Villa Ciani

Poster Session

      • Dr. Charlotte Benson: Improving emotional impact outcomes in adults with desmoid tumours: Post hoc analysis from a clinical study
      • Prof. Bernd Kasper: Improving sleep outcomes in adults with desmoid tumours: Analysis from a clinical study
      • Dr. Bernadette Brennan: Cross-sectional data review from a pediatric desmoid tumours compassionate use program

Hear from desmoid tumour experts

Explore valuable insights from leading international specialists in the field of desmoid tumours

This section features expert interviews, real-world clinical cases, and discussions on the current unmet needs and evolving treatment landscape of this rare and complex condition.

Dr. Sebio – Unmet Needs in the Treatment of Desmoid Tumours
In this video, Dr. Sebio (Consultant Medical Oncologist – Santa Creu i Sant Pau University Hospital, Barcelona, Spain) discusses the key unmet needs in the treatment of desmoid tumours. She explores who is affected, how the disease impacts patients’ quality of life, the limitations of current treatment options, and the urgent need for therapies specifically developed for this condition.
Dr. Sebio – Management of Desmoid Tumour in Clinical Practice: Real-World Patient Case Observation

In this video, Dr. Sebio (Consultant Medical Oncologist – Santa Creu i Sant Pau University Hospital, Barcelona, Spain) presents a real-world clinical case to illustrate the diagnostic and therapeutic journey of a patient with a desmoid tumour. She discusses the diagnostic process, active surveillance, patient communication, treatment decisions, and clinical outcomes.

Dr. Kasper – Unmet Needs in the Treatment of Desmoid Tumours

Dr. Kasper provides a comprehensive overview of desmoid tumours, focusing on their unpredictable behaviour, the burden they place on patients’ daily lives, and the lack of targeted therapies. He highlights the gaps in current clinical management and the need for more specific and effective treatment strategies tailored to this rare disease.

Sign-up to receive updates on Desmoid Tumours​

Listen to a medical oncologist’s perspectives on desmoid tumours

Understanding desmoid tumours

Watch Dr Riedel, medical oncologist from Duke Health and Duke Cancer Institute, provide an overview of desmoid tumours, including pathophysiology, clinical presentations, and impact on patients.

Publication List

Here is a collection of select publications, including guidelines for treatment protocols.

  1. Home – SPAGN – Sarcoma Patient Advocacy Global Network (sarcoma-patients.org) Last Accessed: August 2024.
  2. Bektas M et al. Desmoid tumors: a comprehensive review. Adv Ther. 2023;40(9):3697-3722.